Glenn McEnroe

Title: Glenn McEnroe: Innovator in Antibacterial Compounds

Introduction

Glenn McEnroe is a notable inventor based in San Mateo, California. He has made significant contributions to the field of antibacterial compounds, holding a total of seven patents. His work focuses on developing innovative solutions for treating bacterial infections, particularly those caused by Gram-negative bacteria.

Latest Patents

One of Glenn McEnroe's latest patents involves monobactam organic compounds for the treatment of bacterial infections. This invention pertains to antibacterial compounds of Formula I, along with pharmaceutically acceptable salts and formulations. The invention also includes methods for using these compounds to effectively treat infections. Another significant patent he holds relates to antibacterial agents, which provides compounds of formula (I), including stereoisomers and pharmaceutically acceptable salts. This patent encompasses pharmaceutical compositions, methods for treating bacterial infections, and processes for preparing these compounds.

Career Highlights

Throughout his career, Glenn McEnroe has worked with prominent companies in the biotechnology sector, including Scios Inc. and Achaogen, Inc. His experience in these organizations has allowed him to contribute to the advancement of medical treatments and innovations in antibacterial therapies.

Collaborations

Glenn has collaborated with several professionals in his field, including Sundeep Dugar and Sarvajit Chakravarty. These collaborations have further enriched his research and development efforts in creating effective antibacterial solutions.

Conclusion

Glenn McEnroe's work in the field of antibacterial compounds showcases his dedication to innovation and improving healthcare outcomes. His patents reflect a commitment to addressing critical medical challenges, particularly in the treatment of bacterial infections.